Sunseri named CEO of PMI BioPharma Solutions

Dr. David Sunseri

NASHVILLE - PMI BioPharma Solutions, a specialty CDMO providing Contract Research, Drug Discovery, Development and Manufacturing Services, officially formed in January, 2018, announced that David Sunseri, Ph.D, has been appointed chief executive officer, effective August, 2018. Dr. Sunseri is a highly accomplished pharmaceutical industry executive who previously served as senior vice president, pharmaceutical development and chief business development officer at PMI.

Dr. Sunseri is the son of Ken and Kay Sunseri, of Haleyville.

See complete story in the Northwest Alabamian.
Subscribe now!